Voyager Therapeutics Selects Lead Clinical Candidate for Huntington’s Disease
Jun 01, 2017 11:27 am UTC| Business
CAMBRIDGE, Mass., June 01, 2017 -- Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company developing life-changing treatments for severe neurological diseases, today announced the selection of...
Voyager Therapeutics Selects Lead Clinical Candidate for Huntington’s Disease
Jun 01, 2017 11:27 am UTC| Business
CAMBRIDGE, Mass., June 01, 2017 -- Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company developing life-changing treatments for severe neurological diseases, today announced the selection of...
Voyager Therapeutics Selects Lead Clinical Candidate for Huntington’s Disease
Jun 01, 2017 11:27 am UTC| Business
CAMBRIDGE, Mass., June 01, 2017 -- Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company developing life-changing treatments for severe neurological diseases, today announced the selection of...
Voyager Therapeutics Selects Lead Clinical Candidate for Huntington’s Disease
Jun 01, 2017 11:27 am UTC| Business
CAMBRIDGE, Mass., June 01, 2017 -- Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company developing life-changing treatments for severe neurological diseases, today announced the selection of...
Voyager Therapeutics Selects Lead Clinical Candidate for Huntington’s Disease
Jun 01, 2017 11:27 am UTC| Business
CAMBRIDGE, Mass., June 01, 2017 -- Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company developing life-changing treatments for severe neurological diseases, today announced the selection of...
Voyager Therapeutics Selects Lead Clinical Candidate for Huntington’s Disease
Jun 01, 2017 11:27 am UTC| Business
CAMBRIDGE, Mass., June 01, 2017 -- Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company developing life-changing treatments for severe neurological diseases, today announced the selection of...
Voyager Therapeutics Selects Lead Clinical Candidate for Huntington’s Disease
Jun 01, 2017 11:27 am UTC| Business
CAMBRIDGE, Mass., June 01, 2017 -- Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company developing life-changing treatments for severe neurological diseases, today announced the selection of...
Australia’s Corporate Regulator Urges Pension Funds to Boost Technology Investment as Industry Grows